News Alerts

09 Dec 2018 | 07:29 AM UTC

Israel: 2040 cases of measles reported as of early December /update 2

Israel News Alert

Measles outbreak continues nationwide; at least 2040 cases reported as of early December

TIMEFRAME expected from 12/6/2018, 12:00 AM until 12/15/2018, 11:59 PM (Asia/Jerusalem). COUNTRY/REGION West Bank

Read all related news alert(s):

Event

A measles outbreak is ongoing in Israel, with health officials reporting 2040 confirmed cases between January 1 and early December. According to local sources, the most affected areas include Jerusalem, Tzfat, and Tel Aviv. Health officials have urged citizens to ensure they are vaccinated against the disease.

Context

Measles is a highly contagious viral disease that typically affects mostly children. It is transmitted via droplets from the nose, mouth, or throat of infected persons. The disease remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine.

Symptoms of measles are usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash occurs 14 days after exposure to the virus (within a range of seven to 18 days).

Advice

Individuals in or planning travel to Israel are advised to ensure their measles, mumps, and rubella (MMR) vaccinations are up to date and to contact their doctor with any questions or concerns. Anyone experiencing the above symptoms is urged to seek immediate medical attention.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news